Accelrys Announces DS Accord for Excel
San Diego, CA, July 17 2003
Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc. (NASDAQ: PCOP), today announced the release of its first Discovery Studio(TM) cheminformatics desktop product, DS Accord for Excel. This release makes Accord for Excel’s powerful Microsoft(R) Excel-based tools for managing, visualizing, and analyzing chemical information now available within the Discovery Studio product-line, enabling seamless data-sharing with other Discovery Studio products. The release also features a new ADME (absorption, distribution, metabolism, and excretion) add-on containing models for blood-brain-barrier permeation, human intestinal absorption, aqueous solubility, and serum protein binding.
The new ADME capabilities help to determine the drug potential of a compound by enabling pre-screening of individual structures, compound libraries, and other screening sets with important ADME properties. The ADME models can also be used with the CombiChem add-on module, enabling scientists to design, construct, and refine compound libraries directly within the Microsoft Excel environment prior to laboratory synthesis or biological screening.
“Predictive ADME models help scientists design ‘drug-like’ characteristics into synthesis candidates early,” says Dr. Scott Kahn, chief science officer of Accelrys. “Reducing the number of problematic candidates and focusing on attractive candidates offers substantial quality benefits and cost savings to the pharmaceutical industry.”
DS Accord for Excel helps chemists to solve research problems by enabling them to see, sketch, analyze, and report chemical structures, compound libraries, screening results and other chemical information directly within the familiar Microsoft Excel environment. The Accord engine enables Excel to understand chemical structures as inputs in order to easily perform chemical calculations and graphing.
Discovery Studio products use a best-of-breed approach to offer an advanced, standards-based, accurate, and versatile way to deal with chemical and biological information. In addition to the new ADME add-on, CombiChem and Syracuse add-ons extend the core capabilities of DS Accord for Excel and provide a common working environment for various applications.
Discovery Studio
Discovery Studio is a powerful research environment for the life sciences that delivers a comprehensive suite of informatics, modeling, and simulation solutions. This environment is composed of a wide breadth of tools, client-server applications, and databases for handling the specific research problems encountered by scientists working in the discovery process. The Discovery Studio design enables collaboration across scientific disciplines through a centralized project and knowledge management system, connecting the research conducted by biologists and chemists. In addition, Discovery Studio is an open platform built on industry-standard components so that it can leverage existing IT infrastructure and the integration of third-party applications, public domain, and other in-house developed applications. More information on Discovery Studio can be found at http://www.discovery-studio.com/
About Accelrys
Accelrys is a leading provider of software for computation, simulation, and the management and mining of scientific data used by biologists, chemists, and materials scientists for product design, drug discovery, and development. Accelrys’ technology and services are designed to meet the needs of today’s leading research organizations. The company has two main centers of excellence, which are located in San Diego, and Cambridge, UK. These centers combine research and development with facilities to support significant collaborative projects. Accelrys is a subsidiary of Pharmacopeia, Inc. (NASDAQ: PCOP). More information on Accelrys can be found at http://www.accelrys.com.
More information on DS Accord for Excel can be found at http://www.accelrys.com/dstudio/ds_accord/excel.html
